Substances

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040146505A1
SERIAL NO

10470045

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of a polypeptide which comprises i) a first portion comprising the part of human Fc which binds to CD64, and ii) a second portion comprising one or more heterologous T cell epitopes for stimulating a cytotoxic T cell response. The polypeptide may be an antibody which may be used to stimulate an cytotoxic T cell response against pathogens and tumour cells in patients in need of such treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITEDLONDON NW1 4JL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Durrant, Linda Gillian Nottingham, GB 28 45
Parsons, Tina Nottingham, GB 9 18
Robins, Adrian Nottingham, GB 3 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation